Tumor Targeting: Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells (Adv. Funct. Mater. 27/2015)

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
JournalAdvanced Functional Materials
DOIs
Publication statusPublished - 2015

Cite this